A comparative study of the disease burden attributable to asbestos in Brazil, China, Kazakhstan, and Russia between 1990 and 2019.

BACKGROUND: Brazil, China, Kazakhstan, and Russia are the main asbestos-producing countries, and all forms of asbestos are carcinogenic to humans. The objective of this study was to estimate the disease burden attributable to asbestos between 1990 and 2019 in major producing countries, including Brazil, China, Kazakhstan, and Russia. METHODS: Age-standardized mortality rates (ASMR) and age-standardized disability-adjusted life year (DALY) rates (ASDR) of disease burden attributable to asbestos by country, age, and sex were extracted from the Global Burden of Disease 2019. Percentage change and estimated annual percentage change (EAPC) were used to assess the trends of ASDR and ASMR of disease burden attributable to asbestos between 1990 and 2019. RESULTS: Asbestos-related diseases were highly heterogeneous across Global, Brazil, China, Kazakhstan, and Russia. There was a downward trend in ASMR and ASDR of diseases burden related to asbestos globally. The age-specific mortality rate of disease attributable to asbestos increased in men and women, although it decreased in women aged 85-89, the highest age-specific mortality rate were observed in age 95 + group in men [162.14 (95% UI: 103.76-215.45)] and women [30.58 (95% UI: 14.83-44.33)] per 100 000 population, respectively. Tracheal, bronchus, and lung (TBL) cancer was the leading cause of death and DALYS attributable to asbestos between 1990 and 2019 globally and in Brazil, China, Kazakhstan, and Russia. China had the highest percentage change (73.31%) and EAPC [3.41 (95% CI: 2.75-4.08)] in ASMR related to exposure to asbestos in men, with the highest percentage change (73.31%) and EAPC [3.41 (95% CI: 2.75-4.08)] in ASDR in men. CONCLUSIONS: The ASMR and ASDR of disease burden attributable to asbestos decreased between 1990 and 2019 globally. TBL cancer was the leading cause of death and DALYs attributable to asbestos between 1990 and 2019. There has been an increasing trend in mortality and DALYs globally, especially in older men. The burden of disease attributable to asbestos is increasing in China, especially in men.

Propofol maintains Th17/Treg cell balance and reduces inflammation in rats with traumatic brain injury via the miR­145­3p/NFATc2/NF­κB axis.

Propofol is a commonly used intravenous anesthetic. The aim of the study was to examine the mechanism of propofol in traumatic brain injury (TBI) by regulating interleukin (IL)­17 activity and maintaining the Th17/Treg balance. A rat model with moderate TBI was established using the weight­drop method. Rats with TBI were regularly injected with propofol and their brain injuries were monitored. The peripheral blood of rats was collected to measure the Th17/Treg ratio. MicroRNA (miR)­145­3p expression was detected in the brain tissues of rats and antagomiR­145­3p was injected into the lateral ventricles of their brains to verify the effect of miR­145­3p on brain injury. The downstream target of miR­145­3p was predicted. The targeting relationship between miR­145­3p and nuclear factor of activated T cells c2 (NFATc2) was confirmed. NFATC2 expression and phosphorylation of NF­κB pathway­related proteins were measured. Propofol alleviated brain injury in rats with TBI and maintained the Th17/Treg balance. Propofol upregulated miR­145­3p expression in rat brains, while the inhibition of miR­145­3p reversed the effect of propofol on brain injury. A binding relationship was observed between miR­145­3p and NFATc2. Furthermore, propofol decreased the phosphorylation of p65 and IκBα, and inhibited activation of the NF­κB pathway in the brains of rats with TBI. In conclusion, propofol maintained Th17/Treg balance and reduced inflammation in the rats with TBI via the miR­145­3p/NFATc2/NF­κB axis.

UBE2N Regulates Paclitaxel Sensitivity of Ovarian Cancer via Fos/P53 Axis.

BACKGROUND: Chemo-resistance is still considered one of the key factors in the mortality of ovarian cancer. In this work, we found that ubiquitin-conjugating enzyme E2 N (UBE2N) is downregulated in paclitaxel-resistant ovarian cancer cells. It suggests UBE2N to be critical in the regulation of paclitaxel sensitivity in ovarian cancer. MATERIALS AND METHODS: Ovarian cancer cells with stably overexpressed UBE2N were injected into nude mice to assess tumor growth and paclitaxel sensitivity in vivo. The MTT assay was applied to observe the effect of UBE2N expression on paclitaxel sensitivity. A real-time PCR array, specific for human cancer drug resistance, was used to examine the potential downstream target genes of UBE2N. The expression of UBE2N and potential downstream target genes was determined by Western blotting. The analysis of Gene Ontology and protein-protein interactions of these differentially expressed genes (DEGs) was performed using online tools. To evaluate the prognostic value of hub genes expression for ovarian cancer patients treated with paclitaxel, we applied the online survival analysis tool. RESULTS: Overexpressed UBE2N enhanced the paclitaxel sensitivity of ovarian cancer cells in vitro and in vivo. Thirteen upregulated DEGs and 11 downregulated DEGs were identified when we knockdown UBE2N. Meanwhile, 9 hub genes with a high degree of connectivity were selected. Only Fos proto-oncogene, AP-1 transcription factor subunit (Fos), was overexpressed upon decreasing UBE2N levels, indicating a poor outcome for patients treated with paclitaxel. Moreover, reduced UBE2N could increase Fos expression and reduce P53. Furthermore, reversed regulation of Fos and P53 based on UBE2N reduction could reverse paclitaxel sensitivity, respectively. CONCLUSION: Our study suggests that UBE2N could be used as a therapeutic agent for paclitaxel-resistant ovarian cancer through Fos/P53 pathway. Further studies are needed to elucidate the specific mechanism.

Granulation of biological flocs under elevated pressure: characteristics of granules.

Aerobic granules (AG) have good settling ability and are relatively insensitive to the variation of organic loading rate. When sizes of granules become bigger, substrate and oxygen become limited in the granule core, leading to cell lysis and disintegration of granules. The higher the dissolved oxygen, the deeper the oxygen penetration inside AG. AG operated under elevated pressure might be a possible way to maintain long-term stability of granules. In this study, formation and characteristics of AG in the reactor operated under elevated high pressure (HP) and ambient pressure (AP) are investigated. Results show that both systems removed an average 95% of total organic carbon. Sludge volume index at 5 and 30 min settling times under HP are 35% smaller those under AP, indicating that HP granules have a better settling ability and a denser structure than AP granules. The granule size in the HP system is very uniform, while size distribution in the AP system is broader, indicating that the AP system contains flocculent sludge. Extracellular polymeric substances and polysaccharides (PS) are almost the same for HP and AP; however, exopolymeric protein (PN) is very different. PS/PN ratio for HP sludge is four times that of AP. The result is consistent with sludge settleability, which is improved with increasing PS/PN ratio.

Comparison of high pressure and ambient pressure aerobic granulation sequential batch reactor processes.

Due to granule size, substrate and oxygen become limited in the core of granules leading to cell lysis at the core. Loss of granule stability is still a major barrier for practical application of AG. Compared to ambient pressure condition (AP), operation of AG under high pressure (HP) is a favorable condition for formation and stability of granules. Experimental results show that granulation was facilitated under HP condition. MLSS and size of granules under AP system are higher than those under HP system. However, SS of effluent in AP is higher than those in HP and is consisted mainly of flocculent sludge. Longer SRT and lower biomass yield are obtained in HP system, indicating that less sludge will be produced in HP system. HP system can operate at high nitrogen loading. Complete nitrification was observed earlier in HP, indicating that the growth of NOB was facilitated under high dissolved oxygen.

Dissolution of D2EHPA in liquid-liquid extraction process: implication on metal removal and organic content of the treated water.

Effects of pH, extractant/diluent ratios, and metal concentrations on the extent of extractant dissolution during liquid-liquid extraction were investigated. Experimental result shows that D(2)EHPA dissolution increases dramatically at pH above 4, leveling off at pH 6-7. The phenomenon is consistent with deprotonation of D(2)EHPA and the domination of negatively charged D(2)EHPA species at pH of higher than 4. Concentration of D(2)EHPA in the aqueous phase, i.e., the extent of extractant dissolution, drops after addition of metal and decreases with increasing metal concentration. The amount of D(2)EHPA 're-entering' the organic phase is calculated to be 2.04 mol per mol of Cd added, which is quite closed to the stoichiometric molar ratio of 2 between D(2)EHPA and Cd via ion exchange reaction. The effect of metal species on the extent of extractant/metal complexes re-entering is in the order of Cd ≈ Zn ＞ Ag, which might be coincident to the complexation stability of these metals with D(2)EHPA. The extent of extractant dissolution in liquid-liquid extraction process depends on the type and concentration of metal to be removed, pH of aqueous phase, and extractant/diluent ratios.